Remission of invasive, cancer stem-like glioblastoma xenografts using lentiviral vector-mediated suicide gene therapy

PLoS ONE

Volumn 4, Issue 7, 2009, Pages

  Huszthy, Peter C ^a   Giroglou, Tsanan ^b   Tsinkalovsky, Oleg ^c   Euskirchen, Phillipp ^a   Skaftnesmo, Kai Ove ^a   Bjerkvig, Rolf ^a,d   von Laer, Dorothee ^b   Miletic, Hrvoje ^a  

^a UNIVERSITY OF BERGEN   (Norway)

^b INSTITUTE FOR TUMOR BIOLOGY AND EXPERIMENTAL THERAPY   (Germany)

^c HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^d LUXEMBOURG INSTITUTE OF HEALTH   (Luxembourg)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CD133 ANTIGEN; CELL MARKER; ENHANCED GREEN FLUORESCENT PROTEIN; GAMMARETROVIRAL VECTOR; GANCICLOVIR; HERPES SIMPLEX VIRUS THYMIDINE KINASE; LENTIVIRUS VECTOR; NESTIN; RETROVIRUS VECTOR; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; ASTROCYTE; CANCER GENE THERAPY; CANCER INVASION; CANCER REGRESSION; CONTROLLED STUDY; EMBRYO; GENE TRANSFER; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MULTIPLE CYCLE TREATMENT; MURINE LEUKEMIA VIRUS; NERVE CELL DIFFERENTIATION; NEURAL STEM CELL; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PROTEIN EXPRESSION; RAT; SPHEROID CELL; SUICIDE GENE THERAPY; THERAPY EFFECT; TUMOR RECURRENCE; TUMOR XENOGRAFT; VESICULAR STOMATITIS VIRUS; VIRAL GENE DELIVERY SYSTEM; BRAIN TUMOR; CANCER STEM CELL; GENE THERAPY; GENE VECTOR; GENETICS; LENTIVIRINAE; PATHOLOGY; REMISSION; XENOGRAFT;

ANIMALIA; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; RODENTIA; SIMPLEXVIRUS; VESICULAR STOMATITIS VIRUS;

BRAIN NEOPLASMS; GENE THERAPY; GENETIC VECTORS; GLIOBLASTOMA; HUMANS; LENTIVIRUS; NEOPLASTIC STEM CELLS; REMISSION INDUCTION; TRANSPLANTATION, HETEROLOGOUS;

EID: 67651165115     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0006314     Document Type: Article

References (42)

1. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, et al. (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352: 987-996.
2. Mahesparan R, Read TA, Lund-Johansen M, Skaftnesmo KO, Bjerkvig R, et al. (2003) Expression of extracellular matrix components in a highly infiltrative in vivo glioma model. Acta Neuropathol 105: 49-57.
3. Sakariassen PO, Prestegarden L, Wang J, Skaftnesmo KO, Mahesparan R, et al. (2006) Angiogenesis-independent tumor growth mediated by stem-like cancer cells. Proc Natl Acad Sci U S A 103: 16466-16471.
4. Huszthy PC, Goplen D, Thorsen F, Immervoll H, Wang J, et al. (2008) Oncolytic herpes simplex virus type-1 therapy in a highly infiltrative animal model of human glioblastoma. Clin Cancer Res 14: 1571-1580.
5. Mineta T, Rabkin SD, Yazaki T, Hunter WD, Martuza RL (1995) Attenuated multi-mutated herpes simplex virus-1 for the treatment of malignant gliomas. Nat Med 1: 938-943.
6. Markert JM, Liechty PG, Wang W, Gaston S, Braz E, et al. (2009) Phase Ib trial of mutant herpes simplex virus G207 inoculated pre-and post-tumor resection for recurrent GBM. Mol Ther 17: 199-207.
7. Benedetti S, Bruzzone MG, Pollo B, DiMeco F, Magrassi L, et al. (1999) Eradication of rat malignant gliomas by retroviral-mediated, in vivo delivery of the interleukin 4 gene. Cancer Res 59: 645-652.
8. Kunkel P, Ulbricht U, Bohlen P, Brockmann MA, Fillbrandt R, et al. (2001) Inhibition of glioma angiogenesis and growth in vivo by systemic treatment with a monoclonal antibody against vascular endothelial growth factor receptor-2. Cancer Res 61: 6624-6628.
9. Tamura K, Tamura M, Ikenaka K, Yoshimatsu T, Miyao Y, et al. (2001) Eradication of murine brain tumors by direct inoculation of concentrated high titer-recombinant retrovirus harboring the herpes simplex virus thymidine kinase gene. Gene Ther 8: 215-222.
10. Wang WJ, Tai CK, Kasahara N, Chen TC (2003) Highly efficient and tumor-restricted gene transfer to malignant gliomas by replication-competent retroviral vectors. Hum Gene Ther 14: 117-127.
11. Rainov NG, Ren H (2003) Clinical trials with retrovirus mediated gene therapy-what have we learned? J Neurooncol 65: 227-236.
12. Rainov NG (2000) A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme. Hum Gene Ther 11: 2389-2401.
13. Sandmair AM, Loimas S, Puranen P, Immonen A, Kossila M, et al. (2000) Thymidine kinase gene therapy for human malignant glioma, using replication-deficient retroviruses or adenoviruses. Hum Gene Ther 11: 2197-2205.
14. Beyer WR, Westphal M, Ostertag W, von Laer D (2002) Oncoretrovirus and lentivirus vectors pseudotyped with lymphocytic choriomeningitis virus glycoprotein: generation, concentration, and broad host range. J Virol 76: 1488-1495.
15. Miletic H, Bruns M, Tsiakas K, Vogt B, Rezai R, et al. (1999) Retroviral vectors pseudotyped with lymphocytic choriomeningitis virus. J Virol 73: 6114-6116.
16. Beyer WR, Miletic H, Ostertag W, von Laer D (2001) Recombinant expression of lymphocytic choriomeningitis virus strain WE glycoproteins: a single amino acid makes the difference. J Virol 75: 1061-1064.
17. Fischer YH, Miletic H, Giroglou T, Litwak S, Stenzel W, et al. (2007) A retroviral packaging cell line for pseudotype vectors based on glioma-infiltrating progenitor cells. J Gene Med 9: 335-344.
18. Miletic H, Fischer YH, Neumann H, Hans V, Stenzel W, et al. (2004) Selective transduction of malignant glioma by lentiviral vectors pseudotyped with lymphocytic choriomeningitis virus glycoproteins. Hum Gene Ther 15: 1091-1100.
19. Miletic H, Fischer YH, Giroglou T, Rueger MA, Winkeler A, et al. (2007) Normal brain cells contribute to the bystander effect in suicide gene therapy of malignant glioma. Clin Cancer Res 13: 6761-6768.
20. Bjerkvig R, Tonnesen A, Laerum OD, Backlund EO (1990) Multicellular tumor spheroids from human gliomas maintained in organ culture. J Neurosurg 72: 463-475.
21. Naldini L, Blomer U, Gallay P, Ory D, Mulligan R, et al. (1996) In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272: 263-267.
22. Schambach A, Wodrich H, Hildinger M, Bohne J, Krausslich HG, et al. (2000) Context dependence of different modules for posttranscriptional enhancement of gene expression from retroviral vectors. Mol Ther 2: 435-445.
23. Yee JK, Miyanohara A, LaPorte P, Bouic K, Burns JC, et al. (1994) A general method for the generation of high-titer, pantropic retroviral vectors: highly efficient infection of primary hepatocytes. Proc Natl Acad Sci U S A 91: 9564-9568.
24. Giroglou T, Cinatl J Jr, Rabenau H, Drosten C, Schwalbe H, et al. (2004) Retroviral vectors pseudotyped with severe acute respiratory syndrome coronavirus S protein. J Virol 78: 9007-9015.
25. Huszthy PC, Svendsen A, Wilson JM, Kotin RM, Lonning PE, et al. (2005) Widespread dispersion of adeno-associated virus serotype 1 and adeno-associated virus serotype 6 vectors in the rat central nervous system and in human glioblastoma multiforme xenografts. Hum Gene Ther 16: 381-392.
26. Lee J, Kotliarova S, Kotliarov Y, Li A, Su Q, et al. (2006) Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 9: 391-403.
27. Galipeau J, Li H, Paquin A, Sicilia F, Karpati G, et al. (1999) Vesicular stomatitis virus G pseudotyped retrovector mediates effective in vivo suicide gene delivery in experimental brain cancer. Cancer Res 59: 2384-2394.
28. Ferguson S, Lesniak MS (2007) Convection enhanced drug delivery of novel therapeutic agents to malignant brain tumors. Curr Drug Deliv 4: 169-180.
29. Coil DA, Miller AD (2004) Phosphatidylserine is not the cell surface receptor for vesicular stomatitis virus. J Virol 78: 10920-10926.
30. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, et al. (2004) Identification of human brain tumour initiating cells. Nature 432: 396-401.
31. Galli R, Binda E, Orfanelli U, Cipelletti B, Gritti A, et al. (2004) Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res 64: 7011-7021.
32. Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, et al. (2006) Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444: 756-760.
33. Kelly PN, Dakic A, Adams JM, Nutt SL, Strasser A (2007) Tumor growth need not be driven by rare cancer stem cells. Science 317: 337.
34. Quintana E, Shackleton M, Sabel MS, Fullen DR, Johnson TM, et al. (2008) Efficient tumour formation by single human melanoma cells. Nature 456: 593-598.
35. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, et al. (2003) Identification of a cancer stem cell in human brain tumors. Cancer Res 63: 5821-5828.
36. Beier D, Hau P, Proescholdt M, Lohmeier A, Wischhusen J, et al. (2007) CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. Cancer Res 67: 4010-4015.
37. Wang J, Sakariassen PO, Tsinkalovsky O, Immervoll H, Boe SO, et al. (2008) CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells. Int J Cancer 122: 761-768.
38. Nandi S, Ulasov IV, Tyler MA, Sugihara AQ, Molinero L, et al. (2008) Low-dose radiation enhances survivin-mediated virotherapy against malignant glioma stem cells. Cancer Res 68: 5778-5784.
39. Skog J, Edlund K, Bergenheim AT, Wadell G (2007) Adenoviruses 16 and CV23 efficiently transduce human low-passage brain tumor and cancer stem cells. Mol Ther 15: 2140-2145.
40. Schwartz PH, Bryant PJ, Fuja TJ, Su H, O'Dowd DK, et al. (2003) Isolation and characterization of neural progenitor cells from post-mortem human cortex. J Neurosci Res 74: 838-851.
41. Miletic H, Fischer Y, Litwak S, Giroglou T, Waerzeggers Y, et al. (2007) Bystander killing of malignant glioma by bone marrow-derived tumor-infiltrating progenitor cells expressing a suicide gene. Mol Ther 15: 1373-1381.
42. Tai CK, Wang WJ, Chen TC, Kasahara N (2005) Single-shot, multicycle suicide gene therapy by replication-competent retrovirus vectors achieves long-term survival benefit in experimental glioma. Mol Ther 12: 842-851.